Trials / Terminated
TerminatedNCT03854786
Aerobic Fitness in Overweight and Obese Individuals
A Randomized, Placebo-controlled, Multi-blind Study to Assess the Effect of Oxyjun on Aerobic Fitness in Overweight and Obese Individuals.
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Vedic Lifesciences Pvt. Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
Oxyjun is known for improving cardiovascular endurance. Overweight and obese individuals are at increased risk of cardiovascular complications. To lower the risk, these individuals need to remain physically active with acceptable aerobic fitness. Hence, the objective of the study is to investigate the effect of Oxyjun on aerobic fitness in physically active overweight and obese individuals. All subjects in the study will be tested for maximum aerobic capacity , body composition, and serum biomarker for fitness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Oxyjun | Oxyjun is the proprietary single ingredient product containing high concentrated well standardized aqueous extract of Terminalia arjuna. |
| DIETARY_SUPPLEMENT | Pacebo | Methyl Crystalline Cellulose |
Timeline
- Start date
- 2020-01-03
- Primary completion
- 2020-03-05
- Completion
- 2020-05-28
- First posted
- 2019-02-26
- Last updated
- 2021-01-19
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT03854786. Inclusion in this directory is not an endorsement.